UK Regulators Decide Pregnant Women Don’t Need COVID Vaccines

The United Kingdom’s (U.K.) vaccine advisory committee won’t recommend that pregnant women take the COVID-19 vaccine in 2025-2026, according to a rapid response letter published today in The BMJ.

The Joint Committee on Vaccination and Immunisation (JCVI) made the decision during its Oct. 2 meeting, citing the low risk of serious COVID-19 illness in pregnant women and infants and the vaccine’s cost. The committee did not address safety concerns about the vaccines for pregnant women and their infants.

The committee’s new recommendation — which must be ratified at the next meeting — followed presentations by researchers on COVID-19 epidemiology and cost-effectiveness.

The researchers presented evidence showing that COVID-19 posed a very low risk to pregnant women and their infants and that the vaccines provided minimal benefit.

They concluded that COVID-19 vaccination for pregnant women becomes cost-effective only if the cost of procuring and administering the vaccines could be kept between 10.07 and 13.19 pounds ($12.74-$16.69) per shot. They considered it “very unlikely” that this would be feasible.

The only way to increase the price at which vaccines were considered cost-effective would be if they could show the vaccine averted neonatal deaths from COVID-19 or posed a greater threat to infants. There is no existing data to support this, they said.

Doctors in the U.K. told The Defender they don’t understand why the JCVI hasn’t told them or pregnant women why the committee is waiting until next year to stop recommending the COVID-19 shots to all pregnant women.

Keep reading

Over 300 pages of evidence from the CDC show that vaccines cause autism

I recently received a treasure trove of electronic documents from deep inside the CDC. These documents have never been made publicly available.

The documents include voice-recordings, emails, hand-written notes, diagrams, and data.

The often repeated claim that “vaccines don’t cause autism” is quite simply inconsistent with this evidence which can be authenticated.

I am working with Trevor Fitzgibbon to pitch this to all the mainstream media so that I’m not talking to an echo chamber with this data. It is much better if we can get the blue-pilled media to red-pill their peers; it’s unlikely to happen any other way.

This is a huge scandal and our kids having been paying the price for decades all because the CDC doesn’t want to publicly admit they were wrong

I spoke with a top journalist at Inside Edition who thought that it’s one of the biggest stories of the decade. He said he would try to interest his friends at 60 Minutes and other outlets in viewing the data (the story is too big for IE).

I will keep you apprised.

The documents can be authenticated by people inside and outside the CDC.

I’ve sent the documents to others on our side (just in case something happens to me).

Brian Hooker analyzed the CDC autism study data from the DeStefano paper; the evidence I received confirms what he found

The Hooker paper is published in the scientific peer-reviewed literature and is simply an analysis of the data that the CDC officials told CDC scientist William Thompson to destroy.

Keep reading

What Science Can Say About Vaccines: And What It Can’t Say

Interesting times for science are in store given the incoming administration. RFK, Jr. has been tasked to make America Healthy Again. He will fail where he encourages women to kill the lives inside them, because killing (in case you’ve forgotten) is the opposite of health.

But he might have some success with vaccines. For instance, at a recent interview he said he is against mandatory vaccinations. This brings up the excellent question of what can Science say about vaccines, and what it cannot. The answer will turn out to the same, with only small differences, for many questions similar to vaccination.

Science can answer questions like these, all with more or less certainty, depending on circumstance:

What is the projected range of vaccine protection in a population of given or assumed characteristics? If the vaccine is given in this group at this location, how and with what speed might the disease it protects against progress or decline? What is the range of symptoms and maladies the unvaccinated will experience? What is the protective benefit in the source of these diseases of naturally acquired immunity? How much better is that acquired immunity than the vaccine?

What is the proper dose, perhaps tailored by biology, to achieve the claimed effect?

What are the projected harms caused by the vaccine? Does the vaccine cause other diseases? In what distribution will injuries and other diseases be found?

Science cannot answer questions like these:

Who should get the vaccine? When should it be administered? Where should it be administered? What is the population that will receive the vaccine?

Is it better or worse to suffer the disease? What level of vaccine injury is acceptable? What level of risk of vaccine injury is acceptable? How much better or worse are the symptoms of the disease than the vaccine?

At what level of protection, adjusted by whatever circumstance, should the vaccine be administered? What level of risk for the disease is acceptable and what unacceptable? Is naturally acquired immunity better or worse than the vaccine?

Should it be made mandatory? For all ages in all circumstances? All doses? Should people be made to carry proof of their vaccination? Should a person be fired or otherwise hounded from society for preferring naturally acquired immunity, or because this person does not care about the disease? Should people be forced to care about a disease? Should people be barred from worship until they are vaccinated?

What should be done to scientists who are wrong in their predictions? What about those scientists who lie or are caught exaggerating?

Keep reading

Bacterial DNA a major worry in Jabs

We know about the species of Bacteria used in filthy toxic soups in the production mRNA Jabs, but it appears some people are confused about the extremely high risk of Bacterial DNA contamination in the vile vials and how that varies Lot to Lot.2

Imagine you are swimming inside a vat when they add Sodium Hydroxide to make the live bacteria spill their guts to yield the desired circular Plasmid double stranded DNA. You need to think of the Bacterial DNA which is rolled up into a tight little Nucleoid ball creating delight for topologists plus all the other toxins liberated.3

How effective is the filtration? We know Bacterial DNA is “nicked” by the alkali and even mechanical handling. What tests have been done by Regulatory Authorities.

Have all test results been redacted?

How much Bacterial DNA has been found by indepedent labs?

When BioNTech applied for Emergency Use Authorization in 2020, the scientists assessing the Process 2 Poojabs5 were clearly aware of the risk from Bacterial Host Cell Genomic DNA “impurities”.

Keep reading

The bulk of credible science finds vaccines ‘can and do’ cause autism 

It’s amazing how many media figures remain so uninformed on the proven links between vaccine and autism. Without knowing the subject thoroughly, they keep falsely claiming the links have been “debunked.” 

Quite the opposite. 

I understand, because I was surprised, too, at what I learned when I was first assigned to cover the subject of vaccine safety at CBS News in 2001. At the time, I knew nothing about how vaccines work, scientific studies linking them to autism and many side other effects, or the medical and industry complex set up to defend them at any cost.

As an investigative reporter looking into this topic independently for more than two decades, I have helped expose a lot of what many are desperate to cover up. Some of my work on the topic has received journalism awards, and it has been cited favorably in the New England Journal of Medicine.

The news that’s been revealed in this time period, including compelling studies, testimony, court cases, and other evidence, is now easily accessible to any reporter who knows better than to simply google and get the industry and medical establishment approved narratives; or rely upon information from the vast network of groups, organizations, and fake “fact checkers,” ultimately set up by industry to spin us all.

With Donald Trump about to enter a second term in office, appointing and relying upon figures in public health who are familiar with the facts on these controversies (and willing to act upon them), we are already being exposed to incessant and increasingly desperate propaganda. 

The propagandists have important connections and plenty of money to spend to wield influence, as they long have, with federal agencies, members of Congress, and in media. They support fake “fact check” groups like Health Feedback and Science Feedback, dominate social media narratives, provide “journalism resources” that give false information, control medical information distributed by our once-esteemed public health agencies, influence medical associations, and back nonprofits that are designed to sound independent but put out industry misinformation. 

They have proven they will go to any lengths to protect their billion dollar profits and to try to stop any disruption of the corrupt medical establishment built to support them. 

Keep reading

First Needle-Free Patch RSV Vaccine Being Created

The U.S. National Institutes of Health (NIH) has granted the Biotech company Vaxxas Pty. Ltd. of Australia a worldwide license to a respiratory syncytial virus (RSV) antigen known as DS2. The license will allow for the firm to create the first needle-free and room-temperature stable RSV vaccine using a novel and “cutting edge” high-density microarray patch (HD-MAP). The DS2 antigen was developed at the NIH’s Vaccine Research Center and is designed to elicit a stronger and durable immune response than the currently approved DS-Cav1.1

Vaxxas’ HD-MAP technology is a needle-free vaccine consisting of thousands of tiny projections on a small patch. Each of the micro projections is coated with a dried vaccine formulation. The patch is applied to the skin then delivers the vaccine to immune cells located just beneath the skin’s surface.

The needle-free vaccine platform has gone through five Phase I clinical trials including a second-generation COVID-19 biologic candidate, as well as microarray versions of vaccines for influenza, measles, and rubella. Vaxxas plans to advance its HD-MAP RSV vaccine to a Phase I clinical study after completing preclinical development.1

Keep reading

Most U.S. Health Care Workers Reject COVID-19 Booster Shot This Year

A recent study published in U.S. Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) showed a decline in the uptake of COVID-19 shots among health care workers in the United States this year.1 During the 2023–2024 respiratory virus season, fewer than one in six health care personnel working in acute care hospitals and nursing homes reported receiving a COVID booster, and fewer than one-half of health care personnel working in nursing homes had received a flu shot.2

Findings from the study highlighted that only 15.3 percent of health care workers in acute care hospitals, 10.5 percent in nursing homes, and 12.7 percent of licensed independent practitioners reported receiving the updated COVID booster shot, a sharp drop compared to previous seasons.3 In the 2022-2023 respiratory virus season, 17.8 percent of health care workers in hospitals and 22.8 percent in nursing homes had received a COVID booster.4

This decrease comes after the expiration of a vaccine mandate for health care workers in June 2023, which had been implemented by the Biden administration during the earlier phases of the pandemic in 2021 and 2022. The end of government-funded COVID shots also likely played a role in this lower COVID shot uptake.5

Keep reading

‘A Little Dystopian’: Jeff Bezos, Bill Gates Bankrolling Methane Vaccine for Cattle

Amazon founder Jeff Bezos is investing $9.4 million to develop a vaccine designed to reduce the number of methane-producing microbes in a cow’s stomach, Agriland reported.

The funding comes from his Bezos Earth Fund, a philanthropy he established with $10 billion in 2020. The fund intends to distribute all of its money by 2030, by funding projects to “fight climate change and protect nature.”

Researchers at the United Kingdom’s Pirbright Institute and Royal Veterinary College, and New Zealand’s AgResearch are among the groups receiving funding to research how a vaccine could reduce the methane emitted by cows as they digest and expel food through manure, flatulence and burping.

“Vaccines have proven to be an incredibly cost-effective way to deliver global health solutions,” said Bezos Earth Fund President and CEOAndrew Steer in a press release. “If we can apply this approach to vaccinate cattle and reduce emissions, the scalability and impact could be phenomenal.”

Although scientists have sporadically researched methane vaccines for over four decades, no vaccine yet exists. The project’s first goal is to show that such a vaccine is possible.

“This grant is a moonshot for proof-of-concept — risky bets like this are essential to tackling the climate crisis,” Steer said, according to Agriland.

The researchers will study how methanogens, or methane-producing microbes, colonize the digestive tract of calves and how their immune system responds to those methanogens.

Keep reading

FDA approves Gates-backed bird flu vaccine trial: ‘Disaster waiting to happen’

The FDA has approved the first phase of human trials for a self-amplifying mRNA bird flu vaccine developed by Arcturus Therapeutics, funded by the US government and the Gates Foundation. This vaccine, targeting the H5N1 virus, introduces an enzyme prompting cells to produce more mRNA, leading to sustained antigen production, which experts warn could lead to prolonged immune activation and unknown health risks.

Epidemiologist Dr. Nicolas Hulscher described the FDA’s approval as an opportunity for Arcturus to “experiment with injecting humans with H5N1 bird flu replicon mRNA.” The clinical study is funded by the Biomedical Advanced Research and Development Authority (BARDA), a division of HHS focused on pandemic preparedness. Arcturus also recently received a $928,563 grant from the Gates Foundation, which has long supported mRNA research.

Arcturus claims self-amplifying mRNA vaccines can provide immunity with smaller doses. However, Hulscher warned that even a small dose might be more hazardous due to the vaccine’s self-replicating nature, as the extent of antigen production cannot be precisely measured or controlled.

Keep reading

New Study: A Systematic Review of Autopsy Findings in Deaths Following COVID-19 Vaccination

“Contributed risk from other factors, however, does not exonerate the vaccine, which was used on patients with, and without those risk factors.”

Introduction: Investigating Unanswered Questions

The COVID-19 vaccination program is one of the largest global public health initiatives in history. With over 13 billion doses administered worldwide, serious adverse events must be systematically studied to ensure safety. A newly published systematic review, A Systematic Review of Autopsy Findings in Deaths After COVID-19 Vaccination, by Hulscher et al., examines the role of vaccines in post-mortem cases.

This study reviews 325 autopsy cases, concluding that 73.9% of the deaths were causally linked to COVID-19 vaccination. The leading causes of death included sudden cardiac events, thromboembolic complications, myocarditis, and immune-mediated conditions such as vaccine-induced immune thrombotic thrombocytopenia (VITT). These findings underscore the importance of continuous monitoring and investigation.


Key Findings and Their Context

Of the 325 cases reviewed, causality was assessed using clearly described, standardized criteria, revealing:

  • Sudden cardiac death accounted for 35% of vaccine-related cases.
  • Thromboembolic events (pulmonary embolism and VITT) represented significant contributors at 12.5% and 7.9%, respectively.
  • Myocardial infarction (12%), myocarditis (7.1%), and multisystem inflammatory syndrome (4.6%) were also implicated.

These findings raise sound concerns. Causality assessments in autopsy studies rely on detailed pathological examinations and clinical correlation. These methods are robust in spite of a few hypothetical limitations, such as increased risk due to pre-existing conditions, which may be understudied due to incomplete medical histories.

Keep reading